Interstitial Lung Disease Slide Share
-
Upload
emma-e-vincent -
Category
Documents
-
view
227 -
download
0
Transcript of Interstitial Lung Disease Slide Share
-
8/11/2019 Interstitial Lung Disease Slide Share
1/18
Pulmonary rehabilitation to palliativecare
Emma Vincent
-
8/11/2019 Interstitial Lung Disease Slide Share
2/18
O ILD is a group of lung disorders in whichextensive alteration occurs to both the
alveolar and airway architecture as aresult of inflammation and fibrosis
O The tissue around the alveoli is called
the interstitium. In patients with ILD thetissue becomes stiff or scarred
-
8/11/2019 Interstitial Lung Disease Slide Share
3/18
O Autoimmune RA, lupus, sarcoidosis,Sjogren s
O
Hypersensitivity pneumonitis
dust,fungus or moldO Medications amiodarone, methotrexate,
nitrofuranatoin, narcotic &chemotherapeutic
O Radiation to chestO Occupational asbestos, coal dust, cottonO Others - malignancy
-
8/11/2019 Interstitial Lung Disease Slide Share
4/18
O ILD can occur without a known cause idiopathic
O Idiopathic pulmonary fibrosis (IPF) is themost common cause of this type of ILD
-
8/11/2019 Interstitial Lung Disease Slide Share
5/18
O UIP-
Usual
honeycombO NSIP- Non-specific ground glassO AIP Rapid, diffuse damage ground
glassO DIP now RB-ILD (Respiratory
Bronchiolitis)-smoking relatedO LIP HIV & connective disorders,
Sjogrens
-
8/11/2019 Interstitial Lung Disease Slide Share
6/18
O HRCT always neededO CT images when taken look like snow
splatsO BAL usually taken lymphocytesO Autoimmune group
-
8/11/2019 Interstitial Lung Disease Slide Share
7/18
O Previously known as EAAO Inflammation due variety of inhaled
foreign substance and drug inducedO Variety of appearances sometimes similar
to IPF
-
8/11/2019 Interstitial Lung Disease Slide Share
8/18
-
8/11/2019 Interstitial Lung Disease Slide Share
9/18
OHistoryOPhysical examinationOChest X-rayOPFTs severity, obstruction, restriction,combinationOBloodsOOxygen assessment
OHRCT- depending upon suspected typeO6 minute walk test
-
8/11/2019 Interstitial Lung Disease Slide Share
10/18
O An interstitial pattern with obstruction may
imply: sarcoidosis, HP, combined orconstrictive bronchiolitis.
-
8/11/2019 Interstitial Lung Disease Slide Share
11/18
O BAL sent for cell count, cultures andcytology
O Less helpful with IPF
no predictive rolefor progression or response to therapy
O (VATS only taken in rapid
deterioration/sudden changes)
-
8/11/2019 Interstitial Lung Disease Slide Share
12/18
O Depends upon type and severity:
O Removal of offending agentO Pirfenidone (IPF)O CorticosteroidsO OxygenO Immunosuppressants & cytotoxic agentsO Treatment of complicationsO Pulmonary rehabilitationO Lung transplant
-
8/11/2019 Interstitial Lung Disease Slide Share
13/18
O Information and supportO Symptom control/emotional health
O Supporting treatment regimesO Implementing evidence based care- NICE
2013O Pulmonary rehabilitationO Energy conservationO Advanced life planningO Financial advice
-
8/11/2019 Interstitial Lung Disease Slide Share
14/18
O Lung function and declineO OxygenO
ExerciseO Aiding co-morbidities- physical &
psychologicalO Smoking cessationO Hospital admissionsO ExacerbationsO The future
-
8/11/2019 Interstitial Lung Disease Slide Share
15/18
O Benefits of appropriate oxygen
assessmentO Value of MDTO Value of pulmonary rehabilitationO Symptom controlO Advance life planningO End of life care
-
8/11/2019 Interstitial Lung Disease Slide Share
16/18
O Is there a particular type of ILD that is
more responsive to pulmonaryrehabilitation than another?O Is time of diagnosis to PR referral
relevant?
O Exploring the value of the MDTO Role of oxygenO Advanced care planning
-
8/11/2019 Interstitial Lung Disease Slide Share
17/18
O Monitor disease severity during patientsupport
O Note rate of progressionO Observe patient preferenceO Symptom reliefO Management of co-morbitiesO Support withdrawal of therapiesO End of life care
-
8/11/2019 Interstitial Lung Disease Slide Share
18/18
O ILD management is challenging and everevolving
O Communication of care is vitalO Listening to patient fears is invaluableO The MDT builds a truer picture of patient
needO Patient education is empowermentO Aid their death with ease of breath